Joe Betts-LaCroix
Showing 1–2 of 2 transcripts.
- Milken Institute59 min
Breakthroughs Reshaping Aging and Longevity | Global Conference 2026
Richard Lui, Joe Betts-LaCroix, Tom Hale, Richard Isaacson, Carina Kern, John Whyte
Leaders from Retro Biosciences, Aura Health, Link Jevity, and the AMA convened to discuss accelerating longevity medicine through therapies targeting necrosis and autophagy alongside continuous health monitoring. The panel identified critical systemic barriers including outdated reimbursement models and fragmented disease silos while highlighting breakthroughs like generative AI-driven drug discovery and home-based neuro-insight testing. With a predicted market readiness of 3 to 6 out of 10, the group anticipates the first anti-aging therapeutics will reach consumers within five years as the industry shifts from reactive sick care to proactive aging reversal.
- Y Combinator1h 12m
Cory Doctorow and Joe Betts-Lacroix on Adversarial Interoperability
Cory Doctorow, Joe Betts-Lacroix
This event analyzes the legal and market barriers preventing adversarial interoperability, contrasting historical precedents like Samba with modern constraints posed by software patents and aggressive Terms of Service enforcement. It highlights how entities like Aaron Patzer and HiQ Labs leveraged scraping to build successful businesses before facing litigation, ultimately arguing for regulatory shifts that protect non-industrial copyright uses and allow startups to challenge monopolistic platforms. The discussion concludes with strategic advice for founders to adopt "graceful recovery" infrastructure and use science fiction as a tool to navigate market concentration while building constituencies that can drive future legal change.